How Fee Cuts Could Limit Access to Cardiac Imaging

Noninvasive cardiac imaging helps clinicians investigate heart disease without surgery or catheter-based procedures. Echocardiograms, stress tests, cardiac CT, cardiac MRI and nuclear cardiology studies can reveal reduced blood flow, damaged heart muscle, valve disease, rhythm-related risks and structural abnormalities. These tests often guide treatment before a patient reaches an emergency department or requires an invasive procedure.

When government reimbursement falls below the cost of delivering a safe, timely study, the effects can spread through the entire health system. A cardiology practice may delay replacing an ultrasound machine, reduce appointment capacity, limit bulk-billed services or stop offering complex examinations that require highly trained staff. Patients can then face longer waits, extra travel and higher out-of-pocket costs.

The Campaign for Patient Access was created in the United States to highlight how Medicare physician fee schedule cuts could affect cardiovascular care. Its message has relevance for Australian patients and clinicians because access depends on sustainable funding in every health system. In Australia, Medicare Benefits Schedule payments, private health insurance, hospital budgets and rural workforce shortages all influence whether a patient can obtain cardiac imaging when it is clinically needed.

What Noninvasive Imaging Provides

An echocardiogram is often the first detailed test for suspected heart failure, valve disorders or weakened heart muscle. It is widely used because it does not expose patients to ionising radiation and can be performed in hospitals, specialist rooms and some community settings. Stress echocardiography and nuclear stress testing can show how the heart responds to exertion or medication, helping doctors assess possible coronary artery disease.

Cardiac CT can identify coronary artery narrowing and, in some cases, help exclude significant disease without an invasive angiogram. Cardiac MRI offers highly detailed information about tissue damage, inflammation, congenital abnormalities and heart muscle function. Each modality requires specialised equipment, trained technologists, reporting expertise and quality assurance.

These tests can prevent unnecessary invasive procedures while identifying patients who need rapid treatment. A reliable imaging pathway may allow a general practitioner in Melbourne or Perth to refer a patient for assessment before symptoms become severe. If that pathway becomes harder to access, diagnosis may shift towards emergency care, where the financial and clinical costs are usually higher.

How Payment Cuts Travel to Patients

A reimbursement reduction does not simply remove income from a medical practice. Imaging providers must cover equipment leases, software licences, servicing, accreditation, rent, electricity, administrative staff and specialist interpretation. Machines also have finite operating lives. When payments decline, a practice may have less capacity to maintain equipment or invest in newer technology.

Some providers respond by reducing appointment slots or prioritising examinations with stronger margins. Others may introduce larger patient charges, stop accepting new referrals or refer complex studies to major hospitals. A patient who previously received a bulk-billed echocardiogram could face a gap payment, while someone in a regional area may need to travel several hours to find a provider.

The same pattern has appeared in debates around US Medicare physician payment cuts, where professional groups have warned that unstable reimbursement can weaken cardiovascular services. In Australia, the relevant pressure often involves MBS indexation, changes to diagnostic imaging items, private insurance rebates and rising operating costs. The policy details differ, but the access risk is similar when funding fails to keep pace with the real cost of care.

Australian Access Pressures Are Uneven

Australia’s large cities generally have more cardiologists, imaging providers and hospital services than remote communities. A patient in inner Sydney, Brisbane or Melbourne may have several providers within reasonable travelling distance. Someone in the Northern Territory, far north Queensland or a small town in Western Australia may depend on visiting specialists, limited local equipment or telehealth-supported services.

Travel is more than an inconvenience for older people and those living with heart failure. It can require time away from work, fuel expenses, accommodation and support from family members. Public transport is not always practical for a patient who becomes breathless during exertion, and long-distance travel can be difficult after a stress test or when a person is medically frail.

Australia’s population is also ageing, while cardiovascular disease remains a major cause of illness and hospitalisation. Everyday habits such as long car commutes, sedentary office work, smoking and diets high in processed food can increase cardiovascular risk, although access to preventive care varies widely. Funding decisions that appear modest at a national level can have a sharp effect in communities already experiencing shortages.

Consequences for Diagnosis and Treatment

Longer waits for cardiac imaging can leave symptoms unresolved. Chest discomfort, breathlessness, fatigue and reduced exercise tolerance have many possible causes, and clinical examination alone cannot always distinguish a serious heart condition from a less urgent problem. Delays may lead patients to postpone follow-up, particularly when they must pay a significant gap or take time off work.

A missed or delayed diagnosis can affect the timing of medicines, cardiac rehabilitation, valve monitoring or referral for surgery. Patients with heart failure may deteriorate while waiting for an echocardiogram that would clarify their ejection fraction and guide treatment. People with suspected coronary disease may experience repeated consultations without a definitive test, increasing anxiety and adding pressure to general practice.

Hospitals can also feel the impact. If community imaging becomes less available, more patients may present to emergency departments for symptoms that could have been assessed earlier. Public hospitals in Adelaide, Hobart and regional centres already manage competing demands, including elective surgery backlogs and emergency care. Shifting diagnostic work into hospitals can increase costs while reducing capacity for patients who genuinely require acute treatment.

Why Practices May Change Services

Cardiac imaging is not a single uniform service. A routine transthoracic echocardiogram has different staffing and reporting requirements from a stress echo, cardiac MRI or CT coronary angiogram. Broad payment reductions can make the most complex studies particularly vulnerable because they require specialised operators, strict protocols and time for detailed interpretation.

Practices may also struggle to recruit and retain sonographers, radiographers, nurses and cardiologists if payment levels do not support competitive wages. In Australia, workforce shortages outside the capital cities make this problem more serious. A service may have demand for imaging but still reduce its hours because it cannot staff every appointment safely.

Quality can suffer when providers try to handle more examinations in less time. Rushed patient preparation, limited clinical communication or delayed reports can undermine the value of technically excellent equipment. Sustainable reimbursement should account for the full pathway, including patient identification, image acquisition, interpretation, communication with the referring clinician and follow-up.

Steps That Can Help Preserve Imaging Access

Patients, clinicians and health organisations can make the consequences of funding changes visible by documenting delays, fees and service closures. Clear evidence gives policymakers a stronger basis for assessing whether a payment schedule supports real-world care. Personal stories are especially valuable when they show how a delayed scan affected work, travel, treatment or family responsibilities.

Advocacy should focus on access, quality and clinical outcomes rather than on payment alone. The Campaign for Patient Access model encourages physicians and patients to explain how policy decisions affect cardiovascular services. Australian stakeholders can apply that approach to discussions about MBS item funding, bulk billing, rural outreach, private insurance and public hospital capacity.

• Record waiting times, gap payments, cancelled appointments and travel distances for cardiac imaging.
• Ask local representatives to support funding that reflects equipment, staffing and accreditation costs.
• Include rural, remote, First Nations and low-income patient experiences in policy submissions.
• Protect referral pathways between general practitioners, cardiologists, hospitals and accredited imaging providers.
• Explain to patients why a recommended scan matters and what alternatives may be clinically appropriate.
• Support transparent reporting on imaging availability, bulk-billing rates and regional service gaps.

Better data can also help distinguish genuine overuse from necessary diagnostic care. Appropriate-use criteria, clinical referral guidelines and audit programs can reduce unnecessary testing without making medically indicated imaging harder to obtain. The goal should be to improve value while preserving timely access for patients who need specialist assessment.

Australia’s health system can bring together professional colleges, patient advocates, diagnostic providers, private insurers and government agencies to assess the likely effect of fee changes before they take effect. Early consultation is particularly important when a policy may affect small regional practices that have no financial room to absorb another reduction.

When payment decisions threaten access to noninvasive cardiac imaging, speaking up can protect more than an individual appointment. Patients and clinicians can share documented experiences with professional organisations, Members of Parliament, health departments and relevant consultations. Public attention helps decision-makers see how a fee change reaches the consulting room, the family budget and the hospital emergency department.

Every story should include practical detail: the type of study, the waiting period, the cost, the distance travelled and what happened next. Those accounts can support a stronger case for stable cardiovascular funding and ensure that policy is judged by its effect on timely, safe care.